Free Trial

DocGo (DCGO) Competitors

DocGo logo
$1.49 -0.01 (-0.67%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$1.48 -0.01 (-0.67%)
As of 07/11/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DCGO vs. FLGT, INNV, CSTL, LFMD, CELC, OMDA, FTRE, AUNA, TALK, and SBC

Should you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Fulgent Genetics (FLGT), InnovAge (INNV), Castle Biosciences (CSTL), LifeMD (LFMD), Celcuity (CELC), Omada Health (OMDA), Fortrea (FTRE), Auna (AUNA), Talkspace (TALK), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry.

DocGo vs. Its Competitors

Fulgent Genetics (NASDAQ:FLGT) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

Fulgent Genetics has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, DocGo has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.

Fulgent Genetics presently has a consensus price target of $24.00, indicating a potential upside of 24.55%. DocGo has a consensus price target of $3.56, indicating a potential upside of 138.93%. Given DocGo's higher probable upside, analysts clearly believe DocGo is more favorable than Fulgent Genetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fulgent Genetics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
DocGo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

DocGo has higher revenue and earnings than Fulgent Genetics. DocGo is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fulgent Genetics$283.47M2.07-$42.71M-$1.33-14.49
DocGo$616.55M0.25$19.99M-$0.02-74.50

48.1% of Fulgent Genetics shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 31.8% of Fulgent Genetics shares are owned by insiders. Comparatively, 2.7% of DocGo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Fulgent Genetics had 2 more articles in the media than DocGo. MarketBeat recorded 3 mentions for Fulgent Genetics and 1 mentions for DocGo. DocGo's average media sentiment score of 1.89 beat Fulgent Genetics' score of 1.19 indicating that DocGo is being referred to more favorably in the news media.

Company Overall Sentiment
Fulgent Genetics Positive
DocGo Very Positive

DocGo has a net margin of -0.12% compared to Fulgent Genetics' net margin of -13.94%. DocGo's return on equity of 2.52% beat Fulgent Genetics' return on equity.

Company Net Margins Return on Equity Return on Assets
Fulgent Genetics-13.94% -2.19% -2.02%
DocGo -0.12%2.52%1.70%

Summary

DocGo beats Fulgent Genetics on 10 of the 15 factors compared between the two stocks.

Get DocGo News Delivered to You Automatically

Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DCGO vs. The Competition

MetricDocGoMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$152.97M$7.31B$5.61B$9.11B
Dividend YieldN/A2.81%5.24%4.02%
P/E Ratio-74.5033.1327.9620.25
Price / Sales0.2535.55430.8999.65
Price / Cash3.5523.3737.4658.16
Price / Book0.486.858.045.49
Net Income$19.99M$230.16M$3.18B$250.27M
7 Day Performance-5.99%0.01%3.67%4.80%
1 Month Performance-1.32%0.25%4.09%7.68%
1 Year Performance-52.09%33.80%29.58%16.36%

DocGo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DCGO
DocGo
2.1935 of 5 stars
$1.49
-0.7%
$3.56
+138.9%
-51.0%$152.97M$616.55M-74.504,407Positive News
FLGT
Fulgent Genetics
3.575 of 5 stars
$19.29
-3.8%
$24.00
+24.4%
-6.7%$610.70M$283.47M-14.501,313
INNV
InnovAge
0.9967 of 5 stars
$4.17
-6.5%
$5.00
+19.9%
-22.8%$602.16M$763.85M-18.132,350News Coverage
Gap Down
CSTL
Castle Biosciences
2.3308 of 5 stars
$19.46
-4.1%
$37.00
+90.1%
+6.3%$586.11M$332.07M-102.42540Positive News
LFMD
LifeMD
1.5603 of 5 stars
$12.20
-2.4%
$12.00
-1.6%
+79.9%$568.09M$212.45M-35.88230Analyst Forecast
CELC
Celcuity
2.2703 of 5 stars
$13.34
-3.3%
$28.40
+112.9%
-20.3%$522.18MN/A-4.4040Positive News
OMDA
Omada Health
N/A$18.67
+0.2%
$23.57
+26.3%
N/A$479.72MN/A0.00849Analyst Forecast
Quiet Period Expiration
FTRE
Fortrea
3.8421 of 5 stars
$4.45
-14.8%
$15.00
+237.1%
-79.4%$472.41M$2.70B-0.5115,500Trending News
Analyst Forecast
Gap Down
AUNA
Auna
3.2646 of 5 stars
$6.25
-1.3%
$10.70
+71.3%
-19.9%$468.50M$1.17B10.7714,842
TALK
Talkspace
3.9223 of 5 stars
$2.65
-4.3%
$4.50
+69.8%
+24.5%$463.46M$187.59M132.57500News Coverage
SBC
SBC Medical Group
N/A$4.51
+0.9%
N/AN/A$463.14M$205.42M0.00N/A

Related Companies and Tools


This page (NASDAQ:DCGO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners